UGT1A1-based irinotecan therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for UGT1A1-based irinotecan therapy, covering 2021-12-08 to 2021-12-08. Get the full timeline:
Most recent: Clinical Trial Update: UGT1A1-Based Irinotecan Therapy for Locally Advanced Rectal Cancer [Phase 4]